Prior to joining Hoxie & Associates, Adam earned his Ph.D. in Bioengineering at the University of Notre Dame. Specializing in supramolecular chemistry during his graduate work, Adam has contributed to a wide range of research including the development of nascent supramolecular biomaterials, targeted drug delivery platforms, opioid detection sensors, cancer diagnostic methods, and water purification membranes. With experience in synthetic organic chemistry, protein purification, in vitro modeling, microfluidics, in vivo imaging, genetic engineering, and material science, he is eager to help clients patent creative and innovative technologies. Adam is a patent agent registered to practice before the U.S. Patent and Trademark Office.

Adam can be reached at (973) 912-5232 or abraegelman@hoxpat.com.